Medwave

Cost-effectiveness study of prophylaxis with emicizumab versus bypassing agents in patients with severe hemophilia A in Peru

Ricardo Bitr�n, Camila Pe�a, Paula Arp�n, Nancy Loayza, Katia Salas, Carmen del Villar, Gloria Chumpitaz, Virgilio Salinas (Per�, Chile)
Medwave 2022;22(2):e002118
(15/3/2022)

Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile

Rony Lenz-Alcayaga, Daniela Paredes-Fern�ndez, Karla Hern�ndez-S�nchez, Juan E. Valencia-Zapata (Chile)
Medwave 2021;21(03):e8152
(13/4/2021)

Economic evaluation in health: Cost-utility of the incorporation of total knee replacement to the Chilean Explicit Health-Guarantees regime

Rony Lenz Alcayaga, Daniela Paredes Fern�ndez, Diego Edwards Silva, Pablo G�lvez Ortega (Chile)
Medwave 2020;20(11):e8086
(15/12/2020)

Cost-effectiveness of lenalidomide in combination with dexamethasone compared to bortezomib in combination with dexamethasone for the second-line treatment of multiple myeloma in Chile

Susana Aceituno, Irmina Gozalbo, Marilena Appierto, Luis Liz�n (Spain)
Medwave 2018 May-Jun;18(3):e7220
(29/6/2018)

1